By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chimerix, Inc. 

2505 Meridian Parkway
Ste 340
Durham  North Carolina  27713  U.S.A.
Phone: 919-806-1074 Fax: 919-806-1146



Company News
Data On Chimerix, Inc. (CMRX)'s Brincidofovir Suggests Favorable Resistance Profile In Adenovirus And Cytomegalovirus (CMV) 9/9/2014 7:25:52 AM
Chimerix, Inc. (CMRX) Appoints W. Garrett Nichols, MD, MS As Chief Medical Officer 9/4/2014 10:14:35 AM
Chimerix, Inc. (CMRX)'s Brincidofovir Has In Vitro Activity Against Ebola 9/3/2014 8:00:48 AM
Chimerix, Inc. (CMRX)'s Brincidofovir Selected For Two Oral Presentations Highlighting Resistance Data In CMV And Adenovirus At The 54th Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC) 9/3/2014 7:53:57 AM
Chimerix, Inc. (CMRX) To Present At The Morgan Stanley (MST) Healthcare Conference 9/3/2014 7:34:32 AM
Chimerix, Inc. (CMRX) And Biomedical Advanced Research and Development Authority (BARDA) Announce Continued Partnership In The Development Of Brincidofovir For Smallpox 9/2/2014 9:17:26 AM
Chimerix, Inc. (CMRX) Announces Second Quarter 2014 Financial Results 8/7/2014 8:56:11 AM
Chimerix, Inc. (CMRX) To Announce Second Quarter Financial Results On August 7, 2014 8/1/2014 10:33:53 AM
New Data On Chimerix, Inc. (CMRX)'s brincidofovir Supports Safety And Antiviral Activity Against Multiple Life-Threatening DNA Viruses In Organ Transplant Recipients 7/31/2014 10:44:41 AM
Josh Hardy Going Home After Getting Chimerix, Inc. (CMRX)'s Anti-Viral Drug Brincidofovir 7/18/2014 6:58:24 AM